This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cancer Neoantigen Vaccines
February 2, 2023 | 1-Day Digital Conference
Digital Conference8:00AM EST // 1:00PM GMT // 2:00PM CET
Menu

Guilhem Richard
CTO at EpiVax Therapeutics, Inc
Speaker

Agenda Sessions

  • Distinguishing self-like neoantigens from non-self neoantigens for precision immunotherapies

    , 12:50
    View Session

At this event

Prev
Next
Jenny Zilberberg
Senior Principal Scientist
Imvax Inc

See Guilhem at Cancer Neoantigen Vaccines